I write and edit on biomedical research, information technologies, climate adaptation and other topics that interest me, as a freelancer for publications and non-profit research institutions. Among my day jobs, I was associate director for communications and public affairs at Whitehead Institute for Biomedical Research, founding editor in chief of MIT’s technologyreview.com and executive editor at pcworld.com. Contact: firstname.lastname@example.org, 857.231.0483, @ebender00, 86 Greenlawn Avenue, Newton, MA 02459 USA
Getting a Covid-19 vaccine — quickly and safely
Researchers around the globe are working with unprecedented speed to find the vaccines we need to find our way through the pandemic. What’s the bar for safety and effectiveness?
Forkhead BioTherapeutics: developing a diabetes pill
Scailyte: simplifying difficult diagnoses
Candidates for the Spinoff Prize.
Arming immune foot soldiers against cancer
Natural killer cells are born ready to attack the disease. Biologists are developing ways to make these cells tougher and more targeted.
Will a test to detect early pancreatic cancer ever be possible?
The cancer is often only found after it has spread and when treatment options are limited.
Could a bacteria-stuffed pill cure autoimmune diseases?
Researchers are investigating how the community of microbes living in the gut might help people with multiple sclerosis, lupus and type 1 diabetes.
Unpacking the black box in artificial intelligence for medicine
Deep learning will radically change aspects of our medical care. How well do we need to understand how AI tools work?
Breaking out of the egg
Can the latest techniques speed up the dangerously slow production of flu vaccines?
Now in development: off-the-shelf stem cells
Their potential as universal donors promises to make regenerative medicine more broadly practical.
Biotechs race to develop stem cell treatments for diabetes
Insulin-producing cells grown in the lab could offer a functional cure for the disease.
The Scientist, 2019
Regulating the gene-therapy revolution
The medical regulatory authorities ride a wave of clinical studies for gene therapies.
Getting cancer drugs into the brain
Before they can get to work, treatments for brain cancer must bypass a formidable obstacle — the blood–brain barrier.
Cost of cancer drugs: something has to give
Many patients are being priced out of treatments that could save their lives.
Managed Care Magazine, 2018
With storms intensifying and oceans on the rise, Boston weighs strategies for staying dry
A multi-billion-dollar seawall is among climate adaptation options under consideration for the iconic coastal city.
Putting digital health monitoring tools to the test
Fitbits and smartphone apps can aid in managing chronic conditions–but only if people stay engaged.
Transgenic fish are ready for us. Are we ready for them?
After decades of regulatory and legal challenges, AquaBounty aims to bring genetically engineered salmon to U.S. and Canadian markets next year.